Immune deficiencies following cancer treatment in children

Journal of Tropical Pediatrics

Volumn 49, Issue 5, 2003, Pages 286-290

  Kantar, Mehmet ^a   Çetingül, Nazan ^a   Kansoy, Savaş ^a   Kütükçüler, Necil ^a   Aksu, Güzide ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITOXIN; CD19 ANTIGEN; CD4 ANTIGEN; DIPHTHERIA ANTIBODY; DIPHTHERIA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; SOLID TUMOR; VACCINATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULINS; MALE; NEOPLASMS; TETANUS;

EID: 0142186687     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/49.5.286     Document Type: Article

References (14)

1. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 8: 2221-28.
2. Borella L, Webster RG. The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Res 1971; 31: 420-26.
3. Lehmbecher T, Foster C, Vazquez N, Mackall CL, Chanock SJ. Therapy induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 1997; 19: 399-417.
4. Komada Y, Zhang SL, Zhou YW, et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy. Cancer Immunol Immunother 1992; 35: 271-76.
5. Ogra PL, Sinks LF, Karzon DT. Poliovirus antibody response to in patients with acute leukemia. J Pediatr 1971; 3: 444-49.
6. De vaan GA, van Munster PJ, Bakkaren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia of childhood. Eur J Pediatr 1982; 2: 113-17.
7. Smith S, Schiffman G, Karayalçin G, Bonagura V. Immunodeficiency in long term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy. J Pediatr 1995; 127: 68-75.
8. Alanko S, Pelliniemi T, Salmi TT. Recovery of blood B-lymphocytes and serum immunglobulins after chemotherapy for childhood acute lymphoblastic leukemia. Cancer 1992; 69: 1481-86.
9. Mustafa M, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Ped Hematol Oncol 1998; 20: 451-57.
10. Alanko S, Salmi TT, Pelliniemi TT. Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. Med Ped Oncol 1995; 24: 373-78.
11. Kristinsson VH, Kristinsson JR, Jonmundsson GK, Jonsson OG, Thorsson AV, Haraldsson A. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol 2001; 18: 167-72.
12. Alanko S, Salmi TT, Pelliniemi T. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994; 11: 281-92.
13. Schroder JP, Kuhlmarin WD. Preventive tetanus immunization. Dtsch Med Wochenschr 1992; 117: 1903-6.
14. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells 2000; 18: 10-8.